Mukka Proteins Limited Secures Environmental Consent and Plans Strategic Investment in Middle East

2 min read     Updated on 13 Nov 2025, 04:44 PM
scanx
Reviewed by
Ashish ThakurScanX News Team
Overview

Mukka Proteins Limited has received renewed Consent For Operation from Karnataka State Pollution Control Board for its subsidiary and group entities, valid until September 30, 2032. The company's Board has approved a 68% stake acquisition in United Gulf Fishery Products LLC for approximately Rs. 1.00 crore, expanding its presence in the Middle East. Mukka Proteins also reported strong financial performance for Q2 FY2026, with revenue from operations increasing by 63.93% year-over-year to Rs. 2,445.81 million.

24578100

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Limited , a leading player in the fish and insects protein industry, has announced two significant developments that underscore its commitment to environmental compliance and strategic growth.

Renewed Environmental Consent

The company has received renewed Consent For Operation (CFO-Air, Water) from the Karnataka State Pollution Control Board for its subsidiary Haris Marine Products Private Limited and group entities Mangalore Fish Meal & Oil Company and Ullal Fish Meal & Oil Company. This crucial approval, valid from November 12, 2025, to September 30, 2032, allows the company to continue its industrial activities while adhering to prescribed environmental standards.

The CFO is a mandatory approval under the Water (Prevention & Control of Pollution) Act, 1974, and the Air (Prevention & Control of Pollution) Act, 1981. It confirms that the company's processes, effluent treatment systems, and emission-control measures comply with the environmental standards set by the Pollution Control Board.

Strategic Investment in Middle East

In a move to expand its presence in the Middle East, Mukka Proteins Limited's Board of Directors has approved a strategic investment in United Gulf Fishery Products LLC. The company plans to acquire a 68% stake in United Gulf Fishery Products LLC for approximately Rs. 1.00 crore.

Key details of the acquisition include:

Aspect Details
Target Entity United Gulf Fishery Products LLC
Industry Manufacturing and trading of fish, seafood products, and animal feed
Acquisition Stake 68% of the company's capital
Consideration Cash payment of approximately Rs. 1.00 crore
Completion Timeline Expected by March 31, 2026

This investment aligns with Mukka Proteins Limited's strategic plans to leverage local presence and expertise in the Middle East market. The company is also evaluating the possibility of a future merger between this entity and another group company to achieve operational efficiencies and business synergies.

Financial Performance

For the quarter ended September 30, 2025, Mukka Proteins Limited reported the following consolidated financial results:

Metric Q2 FY2026 (in millions) Q2 FY2025 (in millions) YoY Change
Revenue from Operations Rs. 2,445.81 Rs. 1,491.94 63.93%
Total Income Rs. 2,505.81 Rs. 1,523.34 64.49%
Profit Before Tax Rs. 92.78 Rs. 10.51 782.78%
Profit for the Period Rs. 68.84 Rs. 14.71 368.05%

The company has shown significant year-over-year growth across all key financial metrics, indicating strong performance in the fish and insects protein segment.

These developments demonstrate Mukka Proteins Limited's commitment to sustainable operations and strategic expansion, positioning the company for continued growth in both domestic and international markets.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+3.21%+7.08%-1.44%-17.03%-35.75%-38.41%
Mukka Proteins
View in Depthredirect
like18
dislike

Mukka Proteins Reports Strong Q2 Growth with 360% Surge in Net Profit

2 min read     Updated on 12 Nov 2025, 09:51 PM
scanx
Reviewed by
Ashish ThakurScanX News Team
Overview

Mukka Proteins Limited announced strong Q2 FY2026 results with a 360% YoY increase in net profit to ₹69.00 million. Revenue grew by 63.33% to ₹2.45 billion, while EBITDA rose 115.63% to ₹207.00 million. The company's Board approved a 68% stake acquisition in United Gulf Fishery Products LLC for ₹1.00 crore. Mukka Proteins faces two regulatory matters involving GST-related issues, which it plans to contest.

24510093

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Limited has reported a robust financial performance for the second quarter, showcasing significant growth across key financial metrics.

Financial Highlights

The company's consolidated financial results for Q2 reveal impressive year-over-year growth:

Metric Q2 FY2026 Q2 FY2025 YoY Growth
Net Profit ₹69.00 million ₹15.00 million 360.00%
Revenue ₹2.45 billion ₹1.50 billion 63.33%
EBITDA ₹207.00 million ₹96.00 million 115.63%
EBITDA Margin 8.47% 6.41% 206 bps

The company's performance demonstrates strong growth in profitability and operational efficiency. The substantial increase in net profit and revenue indicates robust demand for Mukka Proteins' products and effective cost management.

Operational Performance

Mukka Proteins' EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) saw a significant rise, more than doubling compared to the same period last year. This improvement, coupled with the expansion in EBITDA margin, suggests enhanced operational efficiency and better cost control measures implemented by the company.

Strategic Investment

In a separate development, Mukka Proteins' Board of Directors has approved a strategic investment in United Gulf Fishery Products LLC. The company plans to acquire a 68% stake for approximately ₹1.00 crore. This move is part of Mukka Proteins' strategy to expand its presence in the Middle East, leveraging the acquired entity's local expertise.

Market Position

Mukka Proteins operates in the fish and insects protein segment, with a significant portion of its revenue coming from international markets. For the half-year ended September 30, 2025, the company reported:

  • Total revenue from operations: ₹4,153.55 million
  • Revenue from India: ₹1,067.30 million
  • Revenue from outside India: ₹2,942.32 million

This revenue distribution highlights the company's strong international presence and its ability to tap into global markets.

Regulatory Matters

The company is currently addressing two regulatory matters:

  1. A Show Cause Notice from the Assistant Commissioner of State Tax, Porbandar, regarding alleged GST return discrepancies. The initial demand of ₹1,410.60 million has been reduced to ₹2.72 million.

  2. A Show Cause Notice from the Directorate General of GST Intelligence, Mangaluru, alleging wrongful availment of Input Tax Credit amounting to ₹43.68 million related to IPO expenses.

Mukka Proteins maintains that these demands are untenable and plans to contest them before the appropriate authorities.

The company's strong financial performance, coupled with its strategic expansion plans, positions Mukka Proteins for potential growth in the coming quarters. However, investors should keep an eye on the ongoing regulatory matters and their potential impact on the company's financials.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+3.21%+7.08%-1.44%-17.03%-35.75%-38.41%
Mukka Proteins
View in Depthredirect
like16
dislike
More News on Mukka Proteins
Explore Other Articles
26.02
+0.81
(+3.21%)